Europe's drug regulator has recommended the addition of a rare type of spinal inflammation as a side-effect of Johnson & Johnson's Covid-19 vaccine, Reuters reports.
It is also assessing reports of capillary leak syndrome following inoculation with Moderna's shot.
The European Medicines Agency said currently there is not enough evidence of a possible link between rare cases of multisystem inflammatory syndrome with mRNA vaccines, including Moderna's shot.
